StemCell Technologies Company Profile: Valuation & Investors

StemCell Technologies Overview

Founded
1993

Status
Private

Employees
2,000

Latest Deal Type
Lev. Recap.

Investors
2

StemCell Technologies General Information

Description

Developer of life science research products. The company's products include cell culture media and supplements, cell isolation products, primary and cultured cells, cytokines, matrices and substrates, enabling scientists to perform stem cell, immunology, cancer, regenerative medicine and cellular therapy research globally.

Contact Information

Website

www.stemcell.com

Ownership Status

Privately Held (backing)

Financing Status

Private Debt Financed

Primary Industry

Biotechnology

Other Industries

Other Devices and Supplies

Laboratory Services (Healthcare)

Primary Office

1618 Station Street
Vancouver, British Columbia V6A 1B6
Canada

+1 (604) 000-0000







Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StemCell Technologies Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Status	Stage
3. Leveraged Recapitalization	20-Aug-2019		000.00	Completed	Generating Revenue
2. Grant	25-Apr-2018	000.00	000.00	Completed	Generating Revenue
1. Debt - General	08-Feb-2018	$12.1M	$12.1M	Completed	Generating Revenue

To view StemCell Technologies’s complete valuation and funding history, request access »

StemCell Technologies Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last
Financing
Details

Developer of life science research products. The company's products include cell culture media and supplements, cell iso

Biotechnology

Vancouver, Canada

2,000 As of 2022

000.00

00000000. 00 000.00

000000

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m

0000000000000

Shirley, NY

000000

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli

0000000000000

Beit Haemek, Israel

000 As of 0000

0000

00.00 0000-00-00

000000&0 0000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

StemCell Technologies Competitors (27)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Creative Biogene	Corporation	Shirley, NY
0000000000 0000000	Formerly PE-Backed	Beit Haemek, Israel	000	0000	000000&0	0000
0000 000000000000	Corporation	San Diego, CA	00		000000000 -
00000000 000000 00	Corporate Backed or Acquired	Santa Ana, CA	000		000000&0
00000	Venture Capital-Backed	Missoula, MT	00	00000	0000000000 0	00000

You’re viewing 5 of 27 competitors. Get the full list »

StemCell Technologies Patents

226
Total Documents Applications and Grants
000
Total Patents Families
28
Granted
12
Pending
000
Expiring in next 12 mo

StemCell Technologies Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)
CA-3174374-A1	Density-adjusted liquids and methods using same	Pending	25-Nov-2020	0000000000
CA-3174380-A1	Systems and methods for differentiating hematopoietic cells	Pending	27-Jul-2020	0000000000
AU-2021224558-A1	Methods and assays with populations of cells	Pending	20-Feb-2020	00000000000
EP-4107253-A1	Methods and assays with populations of cells	Pending	20-Feb-2020	00000000000
EP-4065693-A1	Devices, methods, and assays for biological materials	Pending	26-Nov-2019	C12N5/0677

To view StemCell Technologies’s complete patent history, request access »

StemCell Technologies Executive Team (11)

Name	Title	Board Seat	Contact Info
Sean Marshman	Chief Financial Officer
Andrew Knowles	Chief Operating Officer
Helen Sheridan	Chief Human Resources Officer
John Lilleyman	Chief Information Officer
Sharon Louis	Chief Scientific Officer